  Regulators are now more often distinguishing between perceived good citizens and `` bad actors '' in stem cell and regenerative medicine clinical research , resulting in relatively more polar , carrot-and-stick oversight approaches. Here , I discuss why there may be too much carrot and not enough stick by regulators for effective enforcement.